Chief Executive Officer
Mauro Piantelli has been Head of the Oncopathology Section at the Center of Excellence on Aging) “G. D’Annunzio” Foundation, University of Chieti-Pescara, Italy. Full Professor of Pathology at the University of Chieti-Pescara (1994 up to nowdays)
Chief Scientific Officer
Stefano Iacobelli has been Professor of Medical Oncology at the University “G. D’Annunzio” of Chieti-Pescara, Italy since 1986 and Coordinator of the PhD program in Molecular Oncology since 1991. Dr. Iacobelli has more than 30 years of experience in the translational and clinical Oncology.
He started his career in academic medicine, trained in Europe and the Canada, received board certifications for medical oncology, and served as Chairman of the Italian Consortium of Bio-Oncology.
Pier Giorgio Natali
Director Monoclonal Antibodies
Dr. Pier Giorgio Natali received his MD degree from “La Sapienza” University in Rome, Italy and completed his education with diploma from the Board of American Medical Laboratory Immnunology and advanced training in immunopathology at the Scripps Clinic. He was the Director of the Regina Elena Cancer Institute, Division of Immunology in Rome.
He also served as the Director of the Poloncologico Institute, a leading nationwide institute for oncology treatment in Italy. Dr. Natali is one of the most well-known clinical immunologists also doing basic research. Dr. Natali has published over 350 studies with high Citation Index. He belongs to the Advisory Board of the “CR Journal” edited by the American Association for Cancer Research.